Long-term effects of natural amino acids on infection with Chlamydia trachomatis

Microbial Pathogenesis

Volumn 44, Issue 5, 2008, Pages 438-447

  Gussmann, Joscha ^a   Al Younes, Hesham M ^a,b   Braun, Peter R ^a   Brinkmann, Volker ^a   Meyer, Thomas F ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^b UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Amino acid; Anti chlamydial agent; Chlamydia; Persistence

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; CHAPERONIN; ISOLEUCINE; LEUCINE; METHIONINE; PHENYLALANINE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL VIABILITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINESIS; DNA REPLICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; PROGENY; SUPPLEMENTATION; ULTRASTRUCTURE;

AMINO ACIDS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL LINE; CHLAMYDIA TRACHOMATIS; CULTURE MEDIA; CYTOPLASM; EPITHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; INCLUSION BODIES; MICROSCOPY, ELECTRON, TRANSMISSION; RNA, RIBOSOMAL, 16S;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS; CHLAMYDIAE;

EID: 42049107959     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2007.11.009     Document Type: Article

References (30)

1. Schachter J. Infection and disease epidemiology. In: Stephens R.S. (Ed). Chlamydia: intracellular biology, pathogenesis, and immunity (1999), American Society for Microbiology, Washington, DC 139-169
2. Moulder J.W. Interaction of chlamydiae and host cells in vitro. Microbiol Rev 5 (1991) 143-190
3. Hogan R.J., Mathews S.A., Mukhopadhyay S., Summersgill J.T., and Timms P. Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 72 (2004) 1843-1855
4. Mahony J.B., and Coombes B.K. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?. FEMS Microbiol Lett 197 (2001) 1-9
5. Stamm W.E. Chlamydia trachomatis-the persistent pathogen: Thomas Parran Award Lecture. Sex Transm Dis 28 (2001) 684-689
6. Al-Younes H.M., Brinkmann V., and Meyer T.F. Interaction of Chlamydia trachomatis serovar L2 with the host autophagic pathway. Infect Immun 72 (2004) 4751-4762
7. Gerard H.C., Krausse-Opatz B., Wang Z., Rudy D., Rao J.P., Zeidler H., et al. Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol Microbiol 41 (2001) 731-741
8. Al-Younes H.M., Gussmann J., Braun P.R., Brinkmann V., and Meyer T.F. Naturally occurring amino acids differentially influence the development of Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. J Med Microbiol 55 (2006) 879-886
9. Shaw E.I., Dooley C.A., Fischer E.R., Scidmore M.A., Fields K.A., and Hackstadt T. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol 37 (2000) 913-925
10. Morrison R.P., Lyng K., and Caldwell H.D. Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kDa protein. J Exp Med 169 (1989) 663-675
11. Morrison R.P., Belland R.J., Lyng K., and Caldwell H.D. Chlamydia disease pathogenesis: the 57-kDa chlamydial hypersensitivity antigen is a stress response protein. J Exp Med 170 (1989) 1271-1283
12. Su H., Watkins N.G., Zhang Y.X., and Caldwell H.D. Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesion. Infect Immun 58 (1990) 1017-1025
13. Zhang Y.S., Stewart S., Joseph T., Taylor H.R., and Caldwell H.D. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol 138 (1987) 575-581
14. Hatch T.P., Miceli M., and Sublett J.E. Synthesis of disulfide-bonded outer membrane proteins during the developmental cycle of Chlamydia psittaci and Chlamydia trachomatis. J Bacteriol 165 (1986) 379-385
15. Beatty W.L., Byrne G.I., and Morrison R.P. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 90 (1993) 3998-4002
16. Dreses-Werringloer U., Padubrin I., Jurgens-Saathoff B., Hudson A.P., Zeidler H., and Kohler L. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother 44 (2000) 3288-3297
17. Gerard H.C., Branigan P.J., Schumacher Jr. H.R., and Hudson A.P. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol 25 (1998) 734-742
18. Dreses-Werringloer U., Padubrin I., Zeidler H., and Kohler L. Effects of azithromycin and rifampin on Chlamydia trachomatis infection in vitro. Antimicrob Agents Chemother 45 (2001) 3001-3008
19. Hooton T.M., Rogers M.E., Medina T.G., Kuwamura L.E., Ewers C., Roberts P.L., et al. Ciprofloxacin compared with doxycycline for non-gonococcal urethritis. Ineffectiveness against Chlamydia trachomatis due to relapsing infection. JAMA 264 (1990) 1418-1421
20. Roblin P.M., and Hammerschlag M.R. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrob Agents Chemother 42 (1998) 194-196
21. van der Willigen A.H., Polak-Vogelzang A.A., Habbema L., and Wagenvoort J.H. Clinical efficacy of ciprofloxacin versus doxycycline in the treatment of non-gonococcal urethritis in males. Eur J Clin Microbiol Infect Dis 7 (1988) 658-661
22. Xu F., Schillinger J.A., Markowitz L.E., Sternberg M.R., Aubin M.R., and St Louis M.E. Repeat Chlamydia trachomatis infection in women: analysis through a surveillance case registry in Washington State, 1993-1998. Am J Epidemiol 52 (2000) 1164-1170
23. Coles A.M., Reynolds D.J., Harper A., Devitt A., and Pearce J.H. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis?. FEMS Microbiol Lett 106 (1993) 193-200
24. Harper A., Pogson C.I., Jones M.L., and Pearce J.H. Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect Immun 68 (2000) 1457-1464
25. Allan I., and Pearce J.H. Differential amino acid utilization by Chlamydia psittaci (strain guinea pig inclusion conjunctivitis) and its regulatory effect on chlamydial growth. J Gen Microbiol 129 (1983) 1991-2000
26. Karayiannis P., and Hobson D. Amino acid requirements of a Chlamydia trachomatis genital strain in McCoy cell cultures. J Clin Microbiol 13 (1981) 427-432
27. Kuo C.-C., and Grayston J.T. Amino acid requirements for growth of Chlamydia pneumoniae in cell cultures: growth enhancement by lysine or methionine depletion. J Clin Microbiol 28 (1990) 1098-1100
28. Coles A.M., and Pearce J.H. Regulation of Chlamydia psittaci (strain guinea pig inclusion conjunctivitis) growth in McCoy cells by amino acid antagonism. J Gen Microbiol 133 (1987) 701-708
29. Al-Younes H.M., Rudel T., Brinkmann V., Szczepek A.J., and Meyer T.F. Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell Microbiol 3 (2001) 427-437
30. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic acid Res 29 (2001) e45